MTI

Spectromics develops a diagnostic system that helps to guide antibiotic treatment. It provides a point-of-prescription test for bacterial infections that guides the treatment of antibiotics. Spectromics began operation in 2014. Its headquarters is in Manchester in the United Kingdom.

Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.

Arago’s technology is a platform technology which has been exemplified in its first product offering which is an electrically insulating composite cross-arm for transmission towers. This approach allows tower voltages to be increased without any change to the overall profile of the tower structure or height. It is hoped that rolling out the technology will enable National Grid and other global transmission companies to begin to meet the 50% increase* in electrical energy that is anticipated to flow through the electricity system to facilitate the decarbonisation of energy and the introduction of electric vehicles/heat pumps by 2050.

PowerOasis are a UK based company providing an Energy Management platform that enables Licensees, such as Lithium Ion battery vendors, to build and market new energy propositions and enter new markets. The Platform is a comprehensive software suite which enables the internet of energy by providing control, monitoring and management of all energy generation, energy storage and energy efficiency assets. The 4 layer software architecture, allows the platform to be easily customised to meet the specific needs of licensees.

Oxford Photovoltaics Limited develops and commercializes thin-film perovskite solar cells that are printed directly onto silicon solar cells, CIGS solar cells, or glass. Oxford Photovoltaics Limited has a strategic partnership with Meyer Burger Technology Ltd. The company was incorporated in 2010 and is based in Oxford, United Kingdom.

Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.

Cable-Sense Ltd is a company based in Lancaster, United Kingdom, that specializes in network cabling infrastructure services. Founded in 2004, Cable-Sense offers advanced technology for monitoring, scanning, and mapping network cables, as well as providing services related to network security, audits, and management. The company aims to enhance the efficiency of businesses' cabling infrastructure, making existing Intelligent Infrastructure Management solutions more accessible and cost-effective. By delivering extensive functionality, Cable-Sense helps organizations achieve significant savings in material, energy, and operational costs associated with their cabling networks.

BiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services. Their portfolio of technologies and capabilities includes imaging tools to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. They are also active in the development of new imaging tools for oncology and neuroscience.

Arvia’s ODC combines adsorption with advanced oxidation in a single, scalable unit. Contaminants are concentrated on the surface of Arvia’s patented regenerating adsorbent, Nyex, which allows for targeted and continuous oxidation. The Nyex media is effectively regenerated in-situ and the process can continue without interruption or replacement. Arvia's advanced tertiary drinking & wastewater treatment process enabling the reduction of hard COD, colour & organic micropollutants.

Ai2 Ltd, a biotechnology company, develops anti-infective peptide technology based on the amino acid sequence of a segment of the human protein, Apo lipoprotein E. These peptides exhibit potent broad-spectrum activity against Gram positive and Gram-negative bacteria, fungi, and viruses including resistance strains. Its technology has several applications in healthcare and personal care areas, such as in ophthalmic, oral care, advanced wound care, personal care, and medical devices. The company was founded in 2004 and is based in Manchester, United Kingdom.

PowerOasis are a UK based company providing an Energy Management platform that enables Licensees, such as Lithium Ion battery vendors, to build and market new energy propositions and enter new markets. The Platform is a comprehensive software suite which enables the internet of energy by providing control, monitoring and management of all energy generation, energy storage and energy efficiency assets. The 4 layer software architecture, allows the platform to be easily customised to meet the specific needs of licensees.

Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.

Oxford Photovoltaics Limited develops and commercializes thin-film perovskite solar cells that are printed directly onto silicon solar cells, CIGS solar cells, or glass. Oxford Photovoltaics Limited has a strategic partnership with Meyer Burger Technology Ltd. The company was incorporated in 2010 and is based in Oxford, United Kingdom.

Eykona Medical develops and markets portable three dimensional imaging systems. Its systems are used to capture environments for videogames and in medical imaging for dermatological care. The company is based in Oxford, the United Kingdom.

BiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services. Their portfolio of technologies and capabilities includes imaging tools to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. They are also active in the development of new imaging tools for oncology and neuroscience.

Ai2 Ltd, a biotechnology company, develops anti-infective peptide technology based on the amino acid sequence of a segment of the human protein, Apo lipoprotein E. These peptides exhibit potent broad-spectrum activity against Gram positive and Gram-negative bacteria, fungi, and viruses including resistance strains. Its technology has several applications in healthcare and personal care areas, such as in ophthalmic, oral care, advanced wound care, personal care, and medical devices. The company was founded in 2004 and is based in Manchester, United Kingdom.

Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.

Nano ePrint, Ltd. develops electronic devices. Its products are used in printed and plastic electronics applications, including radio-frequency identification, sensors, and display backplanes. The company also provides intellectual property licences, as well as research, development, and supply chain support services. Nano ePrint, Ltd., formerly known as Plastic ePrint Limited, was founded in 2006. The company is based in Manchester, the United Kingdom.

Lein Applied Diagnostics is an optical metrology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man-made materials. Lein was founded in 2003, initially to develop a non-invasive, pain free glucose meter for the diabetes market. Underpinning this Lein put together a highly qualified, experienced engineering team and built up a strong suite of patents.

DataLase Ltd is the leading provider of materials for laser coding and marking of products and packaging. Their revolutionary materials can be used to create specialised ink solutions that enable the high-speed, in-line digital printing of variable information with lasers allowing late stage customisation. DataLase® proprietary technology can be used on outercase, product and primary packaging to print date and lot codes, 2-D data matrix codes, barcodes, images and graphics across a wide range of markets.

Eleksen Group designs and develops fabric touchpads for use in human machine interface design using its ElekTex technology. The company licenses ElekTex and reference design to manufacturers for use in custom electronics design, as well as markets a range of ready-to-integrate solutions for garment, bags, and accessories manufacturers. It offers sensors for use in soft-goods products, such as apparel and accessory products, as well as in other applications to provide control interfaces.

Global Silicon Limited, a fabless semiconductor company, engages in the design, development, and manufacture of proprietary mixed signal chips for the consumer audio market. It offers CD servo controllers and high performance MP3 and windows media audio (WMA) decoders. The company also offers PCB modules, design wins, and xin servo/mp3/wma. Global Silicon Limited was formerly known as Cheap and Cheerful Chip Company Limited. The company was incorporated in 1997 and is based in Marlow, the United Kingdom with additional offices in Fenggang, Swavesey, and Cambridge, as well as in Shenzhen, the People's Republic of China. Global Silicon Limited is in receivership.

Medisyn Technologies, Inc., a biotechnology company, develops pre-qualified proprietary drug compounds. Its Forward Engineering platform is used for producing compounds for breast, renal, prostate, and lung-cancer treatments. The company also analyzes and optimizes existing drugs, and develops new drug candidates for its partners. In addition, it offers testing and analysis services to predict safety and efficacy of compounds. The company serves biotech and pharmaceutical companies. Medisyn Technologies, Inc. was founded in 1999 and is headquartered in Minnetonka, Minnesota.

Andritz Powerlase Ltd. designs and manufactures high power pulsed lasers for industrial applications that include materials processing. It offers infrared, green, and ultraviolet lasers for HSTB, surface polishing, rust removal, de-painting, cleaning, laser annealing, conservation, surface structuring, and CFRP applications. Andritz Powerlase Ltd. was formerly known as Powerlase Photonics Limited and changed its name to Andritz Powerlase Ltd. in June 2017. The company was founded in 2000 and is based in Crawley, United Kingdom. Andritz Powerlase operates as a subsidiary of Andritz AG.

Founded in 1998, they now have a team with over 200 man-years of embedded systems engineering expertise, with a solid background in the design of 32-bit RISC devices and systems. This includes expertise in real-time systems, VHDL and RTL coding, modeling, application code development in C and assembler languages, and tool development on both UNIX and PC platforms. The three founding members of Beach Solutions remain serving as executive board members of the company.

ApaTech Ltd., an ortho-biologics company, produces synthetic bone repair materials. It offers Actifuse, a synthetic bone graft, which creates a material that promotes the formation of bone and increases the volume of bone formed in the graft/host bone composite structures for small void filling and spinal fusion applications. The company also provides ApaPore, a synthetic and porous hydro-xyapatite grafting for the cemented revision of failed total joint arthroplasties for spinal fusions and fracture fixations, as well as for treating bone defects; and Actifuse MIS Bone Graft Delivery System that offers controlled delivery and precise placement for surgeons performing open and minimally invasive procedures, as well as for use in various spinal and orthopedic procedures, including posterolateral fusion, bone void filling, and acetabular cysts. It offers its products through distributors in the United Kingdom, Ireland, Norway, Sweden, Germany, Austria, Spain, Portugal, Italy, Greece, Turkey, Kuwait, Syria, Australia, and New Zealand. ApaTech Ltd. was founded in 2001 and is based in Elstree, the United Kingdom. It has operations in London, the United Kingdom; Foxborough, Massachusetts; and Berlin, Germany.

Sarantel is a leader in the design of high-performance miniature antennas for portable wireless applications. Sarantel’s revolutionary ceramic filtering antennas offer dramatically improved performance over existing antenna designs, resulting in a clearer signal, better range and a 90 per cent reduction in the amount of signal radiation absorbed by the body. Because of their smaller size and higher capabilities, Sarantel’s antennas enable manufacturers to create innovative wireless products for the GPS, Satellite Radio and Satellite phone markets.

DCT develops, licences and manufactures semiconductor IP, integrated circuits, software and development systems. Founded with personal investments from Turner & Kubiczek, it went on to win a Small Firms Merit Award for Research & Technology from the UK Department of Trade & Industry award for its novel and world-leading performance embedded Java CPU Lightfoot. Following the UK DTI investment, DCT closed two funding rounds with MTI, a global, early-stage Venture Capital investor and set up offices in California and Taiwan. DCT also developed the Bigfoot Java Accelerator IP that found application in video processor ICs. The company was incorporated in 1996 and is currently based in Egham, UK and Shanghai, China. It is presently developing an exciting new version of its Lightfoot architecture, LF v3, that will deliver new performance levels to resource-limited embedded ASSPs.

A provider of enterprise monitoring and data collection software